RESUMO

We describe a case of a gastric neuroendocrine tumor (NET) in a patient with a history of long- term proton pump inhibitor (PPI) use. A 29- year- old man using PPI for the last 10 years due to gastroesophageal reflux disease developed progressive bouts of heartburn. Upper gastrointestinal endoscopy localized an elevated lesion with central depression in the greater curvature of gastric body. Lesion biopsies revealed a well- differentiated neuroendocrine tumor. Despite PPIs have a well- established safety profile, concerns have been raised about a potential relationship between PPI- induced hypergastrinemia and the development of neuroendocrine tumors.

Assuntos

Refluxo Gastroesofágico , Tumores Neuroendócrinos , Neoplasias Gástricas , Masculino , Humanos , Adulto , Inibidores da Bomba de Prótons/efeitos adversos , Tumores Neuroendócrinos/induzido quimicamente , Tumores Neuroendócrinos/patologia , Neoplasias Gástricas/induzido quimicamente , Neoplasias Gástricas/patologia